Endometriosis Management

Introduction to Endometriosis

Endometriosis is a chronic disease that affects a significant population of women of reproductive age, characterized by common symptoms including secondary dysmenorrhea, deep dyspareunia, chronic pelvic pain, and sacral backache with menses, as well as infertility 1
The severity of anatomical distortion in stage 4 disease significantly impacts fertility potential, as highlighted by the World Endometriosis Society consensus 2

The American College of Obstetricians and Gynecologists recommends norethindrone acetate as a first-line treatment for endometriosis, starting at 5 mg daily and gradually increasing to 15 mg daily over 6-9 weeks as needed for symptom control 3
Combined Oral Contraceptives (COCs) provide consistent hormonal suppression but should be considered carefully in patients with cardiovascular risk factors, and are contraindicated in severe hypertension, complicated valvular heart disease, migraines with aura, or history of thromboembolism 4, 5
GnRH Agonists with Add-Back Therapy are effective for pain relief by reducing estrogen production, with a minimum 3-month treatment course, and should always be used with add-back therapy to prevent bone mineral loss 1, 3

The following medications have been found to be effective for endometriosis-associated pain:

Medication	Effectiveness	Side Effects	Contraindications
Depot medroxyprogesterone acetate	Effective for endometriosis-associated pain	Not specified	Not specified
GnRH agonists	Effective for pain relief	Bone mineral loss	Not specified
Danazol	Equally effective to GnRH agonists for pain relief	Not specified	Not specified
Combined Oral Contraceptives (COCs)	Effective for endometriosis, provides consistent hormonal suppression	Irregular bleeding, headache, nausea	Severe uncontrolled hypertension, ongoing hepatic dysfunction, complicated valvular heart disease, migraines with aura or focal neurologic symptoms, complications of diabetes, or history of thromboembolism or thrombophilia

Laparoscopic Excision/Ablation can be considered for patients with persistent symptoms despite medical therapy, and can improve natural fertility by removing adhesions and restoring normal pelvic anatomy, but be aware of recurrence rates up to 44% within one year 1, 2
Surgical options, such as hysterectomy with removal of endometriotic lesions, may be considered for patients who have completed childbearing and have severe symptoms, after initial treatments are ineffective, although approximately 25% of patients experience recurrent pelvic pain after hysterectomy, and 10% require additional surgery 1, 6

Imaging studies such as transvaginal ultrasound or pelvic MRI can help identify endometriotic lesions even in asymptomatic patients, and consideration of endometriosis in the differential diagnosis is necessary even when classic symptoms like dysmenorrhea are absent 2
The American College of Radiology recommends Transvaginal Ultrasound (TVUS) as the first-line imaging modality for detecting deep endometriosis, with expanded TVUS protocols having excellent performance for detection 7
MRI Pelvis is helpful for diagnosis of deep endometriosis and treatment planning, with 92.4% sensitivity and 94.6% specificity in detecting intestinal endometriosis 8
Transrectal Ultrasound allows evaluation of bowel wall layers involved by endometriotic lesions, with 97% sensitivity and 96% specificity for detection of rectovaginal endometriosis 8

The Endometriosis Fertility Index (EFI) is a validated clinical tool for predicting fertility outcomes after surgical staging, as recommended by the European Society of Human Reproduction and Embryology 2
Intrauterine insemination (IUI) may be beneficial for mild-moderate endometriosis but has limited success in stage 4 disease, according to the National Institute for Child Health and Human Development 9
In vitro fertilization (IVF) is often the most effective option for stage 4 endometriosis, as recommended by the Society for Assisted Reproductive Technology 9
Women with stage 4 endometriosis have lower monthly fecundity rates (1-2% vs 15-20% in fertile couples) and cumulative pregnancy rates of approximately 25-35% over 3 years without intervention, according to the American Society for Reproductive Medicine 2

Reducing dietary fat and increasing fiber can help lower circulating estrogen, and considering anti-inflammatory plant-based diet components may be beneficial 1
Vitamin D supplementation may reduce endometrial pain through increased antioxidant capacity 1
Avoid paroxetine and fluoxetine in patients with breast cancer taking tamoxifen, as recommended by the Journal of Clinical Oncology in 2018 3
Consider vaginal DHEA for women with symptoms of vaginal atrophy who have not responded to conservative measures, especially those on aromatase inhibitors, as suggested by the Journal of Clinical Oncology in 2018 3

Regular assessment of symptom control every 3 months and monitoring for side effects of hormonal therapy are essential, as recurrence rates can be 25-44% within 12 months of discontinuing hormonal treatment 10
Endometriosis is associated with a higher risk of hypertension, hypercholesterolemia, and inflammatory conditions, as stated by the American College of Cardiology and the European Society of Cardiology, highlighting the need for careful management of metabolic effects 4, 10
Personalized treatment based on symptom severity, fertility desires, and comorbidities is essential for effective management of endometriosis, according to the American College of Radiology 7

The following factors should be considered when evaluating treatment options for endometriosis:

Factor	Endometriosis	Retroverted Uterus
Primary treatment	Hormonal therapy	Surgical correction of uterine position
Mechanism of pain	Inflammatory lesions, fibrosis	Mechanical pressure/traction during intercourse
Treatment duration	Long-term therapy often required	Potentially permanent correction with surgery
Recurrence rate	25-44% within 1 year	Low recurrence when properly suspended